Actinium Pharmaceuticals Inc (ATNM)

9.85 +0.12 (+1.23%) USD  |  NYAM  |  May 16, 16:00
10.08 +0.23 (+2.34%) After-Hours: 07:23
More

Actinium Pharmaceuticals Current Deferred Revenue (Quarterly)

Current Deferred Revenue (Quarterly) Chart

View Current Deferred Revenue (Quarterly) for ATNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Current Deferred Revenue (Quarterly) Data

View and export this data back to 2021. Upgrade now.
Date Value
September 30, 2022 --
June 30, 2022 --
Date Value
March 31, 2022 --
December 31, 2021 --

Current Deferred Revenue (Quarterly) Range, Past 5 Years

Upgrade
Minimum
Sep 2022
Upgrade
Maximum
Dec 2021
Upgrade
Average
Upgrade
Median
Jun 2022

Current Deferred Revenue (Quarterly) Benchmarks

Perspective Therapeutics Inc --
Eli Lilly and Co --
Cellectar Biosciences Inc --
Outlook Therapeutics Inc --
Bristol-Myers Squibb Co --